510(k) Report

510(k) · Cleared

Recalled · Class II · 2016

Emit-and Methotrexate Assay

K811459510(k) TraditionalCleared Jun 9, 198114-day reviewClass URecalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Syva Co. · LAO Enzyme Immunoassay, Methotrexate

Cleared on Jun 9, 1981 after a 14-day review. FDA has not posted a summary or statement for it, so its predicates are not known. It has been recalled once.

Decided
Jun 9, 1981
Review
14 days
Class
Class U
Product code
LAO
Recalls
1
Predicates
0

FDA has not posted a summary or statement for it, so its predicates are not known.

FIG. 1 — Lineage of K811459Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LAO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LAO device

  1. #1 K233454 ONLINE TDM Methotrexatescore 7.2 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Mar 8, 2016Class IIZ-1618-2016Unknown/Undetermined by firmSiemens Healthcare Diagnostics confirmed that Syva Emit Methotrexate Application (DVMTX.1) for Dimension Vista System does not meet On-Board Stability claim of 20 hours. Testing using reagent at the end of the 20 hours On-Board Stability…

No ancestor or descendant has a Class I recall.

How does its category compare?

All LAO devices

LAO Enzyme Immunoassay, Methotrexate: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LAO

1in 2024

2011: 12017: 12023: 12024: 1
2007high 1 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LAO

Too few LAO 510(k)s in any year since 2007 to give a median.

Recalls per year · LAO

1in 2007

2007: 1
2007high 1 (2007) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LAO

1in 2025

2007: 52009: 12011: 32013: 12014: 32017: 12024: 12025: 1
2007high 5 (2007) · low 0 (2008)2025

MAUDE reports naming product code LAO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—15
20080—00
20090—01
20100—00
20111—03
20120—00
20130—01
20140—03
20150—00
20160—00
20171—01
20180—00
20190—00
20200—00
20210—00
20220—00
20231—00
20241—01
20250—01
20260—0—
Cite this page

510(k) Report. “K811459: Emit-and Methotrexate Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K811459

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026